Article

Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study

Published in: South African Family Practice
Volume 59 , issue 3 , 2017 , pages: 94–97

DOI: 10.1080/20786190.2016.1272230

Author(s): Azhani Mandiwana Botswana Defence Force, Botswana , Stephane Tshitenge Family Medicine and Public Health, Botswana

Keywords: Botswana , HBsAg screening , HIV–HBV co-infection prevalence

Download full text Get new issue alerts

Abstract

Background: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highly active antiretroviral therapy (HAART). This study aimed to determine the prevalence of HIV–HBV co-infection amongst HAART eligible adult patients in some rural settings in Botswana.

« Developing primary health care and public health competencies in undergraduate medical students

Family medicine in South Africa: exploring future scenarios »